Clinical Trial

Venous Ethanol for Ventricular Tachycardia

Study acronym: VELVET
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Comparative effectiveness randomized clinical trial, comparing endocardial radiofrequency ablation alone vs radiofrequency ablation combined with venous ethanol in patients with ischemic ventricular tachycardia -Venous Ethanol for Left Ventricular Ischemic Ventricular Tachycardia -VELVET clinical trial
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-08-19; most recent amendment 2026-07-23.
Status change: Not Yet Recruiting → Recruiting 2023-12-28
Trial Details
NCT Number NCT05511246
Lead Sponsor The Methodist Hospital Research Institute
Conditions Ventricular Tachycardia, Ischemic Cardiomyopathy
Enrollment 156 participants
Start Date 2023-04-12
Primary Completion 2027-12-12 (estimated)
Study Completion 2028-12-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-24